New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:06 EDTWATWaters reports Q2 adjusted EPS $1.22, consensus $1.21
Reports Q2 revenue $481.8M, consensus $476.05M.
News For WAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 28, 2015
11:48 EDTWATWaters price target raised to $120 from $105 at Mizuho
Subscribe for More Information
08:55 EDTWATWaters sees 2015 constant currency sales growth mid-single digits
The company said currency is expected to reduce sales growth by about 6%. Margin is expected to be at or around 59% for 2015. Waters is speaking on its earnings conference call.
08:54 EDTWATWaters sees Q2 EPS $1.20-$1.30, consensus $1.25
Sees Q2 constant currency sales growth at or around 7%. Currency is expected to reduce sales by around 7%. Waters is speaking on its earnings conference call.
08:53 EDTWATWaters sees 2015 EPS $5.67-$5.87, consensus $5.65
08:46 EDTWATWaters says likely to still target smaller, bolt-on acquisitions
Subscribe for More Information
07:14 EDTWATWaters reports Q1 adjusted EPS $1.21, consensus $1.02
Subscribe for More Information
April 27, 2015
15:04 EDTWATNotable companies reporting before tomorrow's open
Subscribe for More Information
April 14, 2015
08:37 EDTWATWaters says CFDA approves UPLC I-Class/Xevo TQ-S system
Waters Corporation announced that the Chinese Food and Drug Administration approved the Waters ACQUITY UPLC I- Class IVD/Xevo TQ-S IVD System for in vitro diagnostic use in China. The system was approved for clinical analysis of a variety of compounds that include diagnostic indicators and compounds for treatment monitoring.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use